Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Development and in vivo evaluation of Irinotecan-loaded Drug Eluting Seeds (iDES) for the localised treatment of recurrent glioblastoma multiforme.
J Control Release. 2020 Aug 10;324:1-16. doi: 10.1016/j.jconrel.2020.05.012. Epub 2020 May 11.
J Control Release. 2020.
PMID: 32407745
The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study.
Garrett AM, Lastakchi S, McConville C.
Garrett AM, et al. Among authors: lastakchi s.
Genes (Basel). 2020 Feb 6;11(2):173. doi: 10.3390/genes11020173.
Genes (Basel). 2020.
PMID: 32041307
Free PMC article.
Item in Clipboard
A Potential New Treatment for High-Grade Glioma: A Study Assessing Repurposed Drug Combinations against Patient-Derived High-Grade Glioma Cells.
Lastakchi S, Olaloko MK, McConville C.
Lastakchi S, et al.
Cancers (Basel). 2022 May 25;14(11):2602. doi: 10.3390/cancers14112602.
Cancers (Basel). 2022.
PMID: 35681582
Free PMC article.
Item in Clipboard
Local administration of irinotecan using an implantable drug delivery device stops high-grade glioma tumor recurrence in a glioblastoma tumor model.
Abdelnabi D, Lastakchi S, Watts C, Atkins H, Hingtgen S, Valdivia A, McConville C.
Abdelnabi D, et al. Among authors: lastakchi s.
Drug Deliv Transl Res. 2024 Feb 6. doi: 10.1007/s13346-024-01524-x. Online ahead of print.
Drug Deliv Transl Res. 2024.
PMID: 38319555
Item in Clipboard
Cite
Cite